Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$0.55 - $1.26 $10,766 - $24,665
19,576 New
19,576 $13,000
Q4 2022

Jan 12, 2023

BUY
$1.02 - $7.48 $18,755 - $137,542
18,388 Added 2.99%
632,749 $747,000
Q3 2022

Oct 27, 2022

SELL
$6.04 - $9.66 $137,542 - $219,977
-22,772 Reduced 3.57%
614,361 $4.63 Million
Q2 2022

Jul 27, 2022

BUY
$4.99 - $8.96 $130,673 - $234,635
26,187 Added 4.29%
637,133 $4.01 Million
Q1 2022

Apr 25, 2022

BUY
$3.84 - $9.74 $1.49 Million - $3.77 Million
387,421 Added 173.32%
610,946 $5.07 Million
Q4 2021

Feb 01, 2022

BUY
$5.12 - $8.19 $1.14 Million - $1.83 Million
223,525 New
223,525 $1.16 Million
Q2 2021

Jul 15, 2021

SELL
$7.82 - $9.23 $3.06 Million - $3.62 Million
-391,708 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$8.44 - $12.66 $1.38 Million - $2.07 Million
-163,473 Reduced 29.44%
391,708 $3.47 Million
Q3 2020

Oct 07, 2020

BUY
$7.96 - $12.42 $3.9 Million - $6.08 Million
489,426 Added 744.32%
555,181 $4.52 Million
Q2 2020

Jul 21, 2020

BUY
$5.4 - $13.37 $355,077 - $879,144
65,755 New
65,755 $631,000
Q3 2019

Oct 16, 2019

SELL
$9.59 - $12.0 $4.26 Million - $5.33 Million
-444,173 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$9.54 - $14.96 $4.24 Million - $6.64 Million
444,173 New
444,173 $4.71 Million

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.